Brainsway Ltd
TASE:BWAY
Net Margin
Brainsway Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IL |
B
|
Brainsway Ltd
TASE:BWAY
|
540.5m ILS |
7%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
223.1B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
183.3B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
150.3B USD |
12%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
139.2B USD |
13%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
108B USD |
13%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.9B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.5B USD |
8%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.8B USD |
75%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
260.8B CNY |
33%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
35.7B USD |
23%
|
Brainsway Ltd
Glance View
Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Brainsway Ltd's most recent financial statements, the company has Net Margin of 7.1%.
You don't have any saved screeners yet